NASDAQ:MGTA
Dianthus Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.magentatx.comipo date
Jun 21, 2018
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and my...Show More
Earnings
Earnings Release in 5 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus